参附注射液辅助治疗老年脑梗死患者的临床观察

目的：探讨参附注射液(简称参附液)治疗老年脑梗死的临床疗效及作用机理。方法：82例老年脑梗死患者随机分为治疗组(用参附液治疗)和对照组(用维脑路通治疗)，治疗前后分别测定血液流变学和血流动力学参数，进行神经功能缺损评分及日常生活能力评价，并观察其临床疗效。结果：治疗组治疗后血液流变学和血流动力学参数、神经功能缺损评分及日常生活能力均较治疗前明显改善(P<0．05或P<0．01)，且优于对照组(P<0．05)。结论：参附液对老年脑梗死患者有较好的疗效，是一种安全、有效的药物．

Clinical Study on Effect of Shenfu Injection in Treating Senile Cerebral Infarction

Objective: To explore the clinical effect and mechanism of Shenfu Injection (SFI) in treating senile cerebral infarction. Methods: Eighty-two aged patients with cerebral infarction were randomly divided into the treated group treated with SFI and the control group treated with Venoruton. The clinical effect was observed, the hemorrheologic and hemodynamic parameters were determined, and the neurofunction deficit scoring and daily life capacity of patients were assessed before and after treatment. Results: After treatment of SFI, the hemorrheologic and hemodynamic parameters, neurofunction deficit scoring and daily life capacity of patients were all significantly improved (P<0.05 or P<0.01), the therapeutic effect of SFI was better than that of Venoruton (P<0.05). Conclusion: SFI has good effect in treating senile cerebral infarction, which is a safe and effective drug.